Geneva Partners’s Align Technology ALGN Stock Holding History

Geneva Partners’s Portfolio ALGN Stock Details ALGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,572	Closed	-$5.04M	–	99
2021 Q3	$5.04M	Buy	+7,572	New	+$5.14M	2.39%	16

Other funds holding ALGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geneva Partners's ALGN Position: Q4 2021 in Review

Geneva Partners sold out of Align Technology (ALGN) in Q4 2021, closing a stake of 7,572 shares — an estimated $5.04M sold.

Geneva Partners first reported a position in ALGN in Q3 2021 and held it in 1 quarter. The position peaked at $5.04M in Q3 2021. 931 funds tracked by Wall St. Rank hold ALGN as of Q4 2021.

Geneva Partners reported no remaining Align Technology position as of Q4 2021 after selling out during the quarter.
Geneva Partners sold 7,572 Align Technology shares in Q4 2021, an estimated $5.04M.
Geneva Partners first reported a position in Align Technology in Q3 2021 and held it in 1 quarter.
Geneva Partners's Align Technology position peaked at $5.04M in Q3 2021.
931 funds tracked by Wall St. Rank held Align Technology as of Q4 2021.

Based on Geneva Partners's 13F filing for Q4 2021, filed 31 Jan 2022.